Replies to post #16617 on GeneSYS ID Inc fka GNID

[StockMedic1]

Actually, I always give credit where credit is due. And the amount of analysis by YD should not be discounted. But as much DD he has provided demonstrating one side of the story, it would be brilliant had he approached both sides. I understand why he does this (to some degree anyway), but am looking forward to future analysis from him that includes both sides.

[DCorleone]

FREE Business Advice CH as it pertains to RXSF... If you think they are part of the PROBLEM, it is to your Advantage to make them part of the SOLUTION.

[@LiftedCapital]

BEAUTIFUL ~~>>

RXSF